A common variant of CDKN2A (p16) predisposes to breast cancer
暂无分享,去创建一个
S. Narod | C. Szczylik | A. Mackiewicz | S. Góźdź | C. Cybulski | T. Byrski | T. Huzarski | J. Gronwald | E. Grzybowska | T. Dębniak | B. Górski | O. Zambrano | O. Haus | M. Stawicka | S. Gozdecka-Grodecka | K. Urbański | P. Wandzel | D. Surdyka | E. Kowalska | S. Narod | J. Lubiński | S. Niepsuj | M. Posmyk | B. Waśko | A. Rozmiarek | M. Swiec
[1] J. Kładny,et al. CDKN2A common variants and their association with melanoma risk: a population-based study. , 2005, Cancer research.
[2] J. Kładny,et al. CDKN 2 A Common Variants and Their Association with Melanoma Risk : A Population-Based Study , 2005 .
[3] J. Lubiński,et al. CHEK2 is a multiorgan cancer susceptibility gene. , 2004, American journal of human genetics.
[4] Y. Iwamoto,et al. Alterations of the p16INK4a/p14ARF pathway in clear cell sarcoma , 2004, Cancer science.
[5] R. Scott,et al. Germline mutation and large deletion analysis of the CDKN2A and ARF genes in families with multiple melanoma or an aggregation of malignant melanoma and breast cancer , 2004, International journal of cancer.
[6] T. Kręcicki,et al. Inactivation of the cyclin‐dependent kinase inhibitor 2A (CDKN2A) gene in squamous cell carcinoma of the larynx , 2004, Molecular carcinogenesis.
[7] A. Godwin,et al. Identification of a splice acceptor site mutation in p16INK4A/p14ARF within a breast cancer, melanoma, neurofibroma prone kindred , 2003, Journal of medical genetics.
[8] R. Schneider-Stock,et al. Hereditary p16-Leiden mutation in a patient with multiple head and neck tumors. , 2003, American journal of human genetics.
[9] J. Barrett,et al. An assessment of the CDKN2A variant Ala148Thr as a nevus/melanoma susceptibility allele. , 2002, The Journal of investigative dermatology.
[10] K. Lamperska,et al. Analysis of mutations in the p16/CDKN2A gene in sporadic and familial melanoma in the Polish population. , 2002, Acta biochimica Polonica.
[11] G. Landberg,et al. Methylation of the p16(Ink4a) tumor suppressor gene 5'-CpG island in breast cancer. , 2001, Cancer letters.
[12] F. Bosman,et al. Methylation Silencing and Mutations of the p14ARF and p16INK4a Genes in Colon Cancer , 2001, Laboratory Investigation.
[13] J. Fraumeni,et al. Germ-line p 53 Mutations Predispose to a Wide Spectrum of Early-onset Cancers 1 , 2001 .
[14] A. Jakubowska,et al. Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer. , 2000, American journal of human genetics.
[15] Kerstin,et al. High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. , 2000, Journal of the National Cancer Institute.
[16] P. Bruzzi,et al. Characterization of ligurian melanoma families and risk of occurrence of other neoplasia , 1999, International journal of cancer.
[17] D. Duffy,et al. CDKN2A variants in a population-based sample of Queensland families with melanoma. , 1999, Journal of the National Cancer Institute.
[18] C. Markopoulos,et al. Alterations of p16-pRb Pathway and Chromosome Locus 9p21–22 in Sporadic Invasive Breast Carcinomas , 1998, Molecular medicine.
[19] G. Peters,et al. The p16INK4a/CDKN2A tumor suppressor and its relatives. , 1998, Biochimica et biophysica acta.
[20] E Gabrielson,et al. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[21] M. Bisogna,et al. Hypomethylation and increased gene expression of p16INK4a in primary and metastatic breast carcinoma as compared to normal breast tissue , 1998, Oncogene.
[22] M. Tucker,et al. CDKN2A mutations in multiple primary melanomas. , 1998, The New England journal of medicine.
[23] R. Sutherland,et al. Cancer‐associated mis‐sense and deletion mutations impair p16INK4 CDK inhibitory activity , 1996, International journal of cancer.
[24] P. Goodfellow,et al. Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene. , 1995, The New England journal of medicine.
[25] H. Varmus,et al. Mutations associated with familial melanoma impair p16INK4 function , 1995, Nature Genetics.
[26] G. Hannon,et al. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 , 1993, Nature.